Mylan launches generic hypertension drug in US

Generics |  Regulatory | By BioSpectrum Bureau  | 2 Comment | 10 Jul, 2014

Singapore: Global pharmaceutical firm, Mylan, has launched Telmisartan tablets-20 mg, 40 mg and 80 mg, the generic versi...Read more

New tech promises revenue boost for drug makers

Generics |  Influencers | By BioSpectrum Bureau  | 2 Comment | 12 Jun, 2013

Australian drug delivery technology company Imugene has developed Linguet, a drug delivery technology platform, to impro...Read more

Abbott to sell branded generics business to Mylan

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

Singapore: Global pharmaceutical firm Abbott is planning to sell its developed markets branded generics pharmaceuticals ...Read more

Another Ranbaxy plant faces US FDA ire

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jan, 2014

Singapore: The year 2014 is bringing back haunting memories of the way the year gone by had started for India's biggest ...Read more

Takeda diabetes drug gets China's import license

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

Singapore: China's State Food and Drug Administration (SFDA) issued an Import Drug License (IDL) for Takeda's type 2 di...Read more

Dr. Reddy's launches Aricept generic Donepezil

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

Singapore: Dr. Reddy's Laboratories has launched Donepezil Hydrochloride tablets, 23 mg, a therapeutic equivalent generi...Read more

Japan pharma to grow at 2% CAGR from 2013-20

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 11 Jul, 2013

Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan...Read more

ULURU inks pact with Japanese medical firm

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2016

Texas-headquartered ULURU Inc has expanded its distribution network by entering into a cooperation agreement with Saraya...Read more

Japan approves generic drug for osteoporosis

Generics |  Regulatory | By BioSpectrum Bureau  | 2 Comment | 28 Dec, 2012

Singapore: Actonel 75 mg tablets and Benet 75 mg tablets, a once-monthly formulation of risedronate sodium hydrate (gene...Read more

Teva launches generic of cancer drug Temodar in US

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2013

Singapore: Israel-based Teva Pharmaceutical and US-based Perrigo have launched generic version of cancer drug Temodar (t...Read more

Taiwan firm gets ANDA approval for generics of Pfizer's Procardia

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2014

Singapore: Taiwan's TWi Pharmaceuticals has recieved ANDA approval of the generic equivalent to Procardia XL (Nifedipine...Read more

Takeda gets Japanese NDA approval for obesity drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labo...Read more

MHRA issues import alert to Wockhardt's India plant

Generics |  Regulatory | By BioSpectrum Bureau  | 2 Comment | 09 Jul, 2013

Singapore: About two months after the US Food and Drug Administration (US FDA) issued a Form 483 to Wockhardt for drug q...Read more

Irish firm's track-&-trace system to curb fake drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at ...Read more

Mylan launches generic version of Sporanox

Generics |  Regulatory | By BioSpectrum Bureau  | 2 Comment | 30 Jul, 2012

Singapore: Mylan Pharmaceuticals received final approval from the US FDA for its abbreviated new drug application (ANDA)...Read more

Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...Read more

AstraZeneca, BMS gets FDA nod for diabetes drug

Generics |  Regulatory | By BioSpectrum Bureau  | 2 Comment | 09 Jan, 2014

Singapore: AstraZeneca and Bristol-Myers Squibb have recieved U.S. Food and Drug Administration (FDA) approval for diabe...Read more

Ranbaxy advisory: All our products are safe and efficacious

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...Read more